Predictive model for the diagnosis of ectopic Cushing syndrome

View at publisher
Authors: Wilfredo Antonio Rivera Martínez, Carlos Esteban Builes-Montaño, Natalia Aristizábal Henao, Stefania Cruz Calderón, Néstor Andrés Díaz Posada, María Johana Ramírez Castaño, Carlos Alfonso Builes Barrera, Claudia Marcela Gómez Serna, Alejandro Román González, Alin Abreu Lomba, Andrés Felipe García Ramos, David Vernaza
+24 more Alfonso Soto Moreno, Ana Irigaray Echarri, María Dolores Ollero García-Agulló, María Dolores Moure Rodríguez, Alejandro Pinzón Tovar, Rogelio García-Centeno, L Beltrán Fernández, Andrés Cardona, Betina Biagetti, Fernando Guerrero-Pérez, Luis Candil Valero, Ana Castro Luna, Miguel Paja, Rosa Cámara, Johnayro Gutiérrez Restrepo, Pablo Alberto Castaño Ceballos, Néstor López Pompey, Pedro Iglesias, Victoria Alcázar, Edelmiro Menéndez Torre, Claudia Lozano Aida, Pol Candela, Felicia Hanzu, Marta Araujo Castro
Cited by: 1
References: 27

Abstract

The purpose of our study was to develop and externally validate a multivariable diagnostic model to distinguish ectopic ACTH secretion (EAS) from Cushing's disease (CD) using routine clinical parameters. The model was derived from a Spanish multicenter retrospective cohort and externally validated in a Colombian cohort. Predictors were selected through a multivariable logistic regression model with penalized logistic regression (LASSO) using the Spanish cohort. Discriminative performance was assessed using the area under the ROC curve (AUC) and calibration using the slope, the origin, and the Brier score. The derivation cohort included 253 patients from Spain (199 with CD and 54 with EAS). The external validation cohort comprised 72 Colombian patients (53 with CD and 19 with EAS). In the derivation cohort, multivariable modeling identified four independent predictors: ACTH concentration, 24-h urinary free cortisol (UFC), serum potassium, and maximum pituitary tumor diameter. The final model demonstrated good discrimination in the derivation cohort (mean AUC of 0.987), with excellent calibration (calibration slope ranged from 0.998 to 5.22, intercept -0.2 to 0.99, Brier score 0.035). In external validation, model performance remained robust (AUC ranging from 0.9885 to 0.9890; Brier score 0.0381). The model achieved a sensitivity of 95.3%, specificity of 93.6%, positive predictive value of 82.3%, and negative predictive value of 98.7% for detecting EAS. Thus, the diagnostic model developed, based on routinely available clinical variables, shows high accuracy and calibration in differentiating between EAS and CD, supporting its potential use in diverse clinical settings and integration into diagnostic workflows.

Fields of Study & Subjects

Pituitary Gland Disorders and Treatments Adrenal Hormones and Disorders Adrenal and Paraganglionic Tumors

Publication details

Journal / source
Endocrine Related Cancer
Publisher
Bioscientifica
Volume
33
Issue
6
Publication date
16 April 2026
Language
EN